血管紧张素Ⅱ抑制剂防治慢肝、肝硬化的临床研究进展

宋怀宇; 孙成刚

血管紧张素Ⅱ抑制剂防治慢肝、肝硬化的临床研究进展

详细信息

中图分类号: R575.2
计量
- 文章访问数: 2030
- HTML全文浏览量: 7
- PDF下载量: 803
- 被引次数: 0
出版历程
- 出版日期: 2003-04-20

摘要

HTML全文

参考文献(11)

[1]Ching HT, Cheng JS, Lin M, et al. Haemodynamic effects of enalaprilat on portal hypertension in patients with HBsAg-positive cirrhosis[J]. J Gastroenterol Hepatol, 1995, 10 (3) ∶256-260.

[2]Ibarra FR, Afione C, Garzon D, et al. Portal pressure, renal function and hormonal profile after acute and chronic captopril treatment in cirrhosis[J].Eur J Clin Pharmacol, 1992, 43 (5) ∶477-482.

[3]Amarapurkar DN, Dhawan P, Kalro RH, et al. Role of routine estimation of creatinine clearance in patients with liver cirrhosis[J].Indian J Gastroenterol, 1994, 13 (3) ∶79-82.

[4]Ohnishi A, Murakami S, Harada M, et al. Renal and hormonal responses to repeated treatment with enalapril in non-azotemic cirrfiosis with ascites[J]. J Hepatol, 1994, 20 (2) ∶223-230.

[5]Van Vliet AA, Hackeng WH, Donker AJ, et al. Efficacy of lowdose captopril in additiion to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis[J]. J Hepatol, 1992, 15 (1-2) ∶40-47.

[6]Tsai YT, Lin HC, Lee FY, et al. Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis[J]. Proc Nad Sci Counc Repub China B, 1996, 20 (2) ∶44-50.

[7]Gentilini P, Romanelli RG, La Villa G, et al. The liver effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of [J].Gastroenterology, 1993, 104 (2) ∶588-594.

[8]Benedict CR, Refino CJ, Bruce A, et al. New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human tp-A[J]. Circulation, 1995, 92 (10) ∶3032-3040.

[9]Pozzi M, Carago S, Boari G, et al. Evidence of functional and structural cardiac abnormalities in cirrhosis patients with and without ascites[J]. Hepatology, 1997, 26 (5) 1131-1137.

[10]Schneider A W, Ksalk JF, Klein CP, et al. Effect of losartan, an angiotensinⅡ receptor antagonist, on portal pressure in cirrhosis[J]. Hepatolo, 1999, 29∶334-339.

[11]Girgrah N, Lia P, Collier J, et al. Haemodynamic, renal sodium handing and neurohormonal, effects of acute administration of low dose losartan, an angiotensinⅡ antagonist, in preascitic cirrhosis[J]. Gut, 2000, 46 (1) ∶114-120.

施引文献

资源附件(0)

访问统计